The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Top Cited Papers
- 1 February 2011
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 377 (9767) , 741-750
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT ProjectClinical Trials, 2010
- REPRINTCirculation, 2007
- Can We Improve the Statistical Analysis of Stroke Trials?Stroke, 2007
- Prevalence of elevated blood pressure in 563 704 adult patients with stroke presenting to the ED in the United StatesThe American Journal of Emergency Medicine, 2007
- Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary PreventionStroke, 2005
- High Blood Pressure in Acute Stroke and Subsequent OutcomeHypertension, 2004
- The ACCESS StudyStroke, 2003
- Predictors of stroke outcome using objective measurement scales.Stroke, 1990
- Isradipine in Patients with Acute Ischaemic Cerebral InfarctionDrugs, 1990
- Recovery of motor function after stroke.Stroke, 1988